GB9201692D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB9201692D0
GB9201692D0 GB929201692A GB9201692A GB9201692D0 GB 9201692 D0 GB9201692 D0 GB 9201692D0 GB 929201692 A GB929201692 A GB 929201692A GB 9201692 A GB9201692 A GB 9201692A GB 9201692 D0 GB9201692 D0 GB 9201692D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929201692A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Intercredit BV
Original Assignee
SmithKline Beecham Intercredit BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Intercredit BV filed Critical SmithKline Beecham Intercredit BV
Priority to GB929201692A priority Critical patent/GB9201692D0/en
Publication of GB9201692D0 publication Critical patent/GB9201692D0/en
Priority to AU34942/93A priority patent/AU3494293A/en
Priority to PCT/EP1993/000176 priority patent/WO1993015071A1/en
Priority to EP93903880A priority patent/EP0625151A1/en
Priority to JP5512931A priority patent/JPH07503023A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB929201692A 1992-01-27 1992-01-27 Compounds Pending GB9201692D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB929201692A GB9201692D0 (en) 1992-01-27 1992-01-27 Compounds
AU34942/93A AU3494293A (en) 1992-01-27 1993-01-26 Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors
PCT/EP1993/000176 WO1993015071A1 (en) 1992-01-27 1993-01-26 Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors
EP93903880A EP0625151A1 (en) 1992-01-27 1993-01-26 Thiazolyl-pyridine derivatives and their use as gastric acid secretion inhibitors
JP5512931A JPH07503023A (en) 1992-01-27 1993-01-26 Thiazolylpyridine derivatives and their use as gastric acid secretion inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929201692A GB9201692D0 (en) 1992-01-27 1992-01-27 Compounds

Publications (1)

Publication Number Publication Date
GB9201692D0 true GB9201692D0 (en) 1992-03-11

Family

ID=10709305

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929201692A Pending GB9201692D0 (en) 1992-01-27 1992-01-27 Compounds

Country Status (5)

Country Link
EP (1) EP0625151A1 (en)
JP (1) JPH07503023A (en)
AU (1) AU3494293A (en)
GB (1) GB9201692D0 (en)
WO (1) WO1993015071A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436966B1 (en) 1997-10-27 2002-08-20 Takeda Chemical Ind., Ltd. Adenosine A3 receptor antagonists
AU2001244618A1 (en) 2000-03-30 2001-10-15 Takeda Chemical Industries Ltd. Substituted 1,3-thiazole compounds, their production and use
UA80393C2 (en) 2000-12-07 2007-09-25 Алтана Фарма Аг Pharmaceutical preparation comprising an pde inhibitor dispersed on a matrix
GB0102668D0 (en) * 2001-02-02 2001-03-21 Glaxo Group Ltd Compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
AU2003256003A1 (en) 2002-09-18 2004-04-08 Pfizer Products Inc. Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors
MXPA05002982A (en) * 2002-09-18 2005-06-22 Pfizer Prod Inc Triazole derivatives as transforming growth factor (tgf) inhibitors.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0149884B1 (en) * 1983-09-09 1992-12-16 Takeda Chemical Industries, Ltd. 5-pyridyl-1,3-thiazole derivatives, their production and use
US4697012A (en) * 1984-07-25 1987-09-29 Merck & Co., Inc. Morpholino pyridyl thiazole compound
US5021435A (en) * 1988-01-22 1991-06-04 Sumitomo Pharmaceuticals Company, Limited Certain pyridyl-thiazolidin-4-one having anti-ulcer activity

Also Published As

Publication number Publication date
JPH07503023A (en) 1995-03-30
WO1993015071A1 (en) 1993-08-05
AU3494293A (en) 1993-09-01
EP0625151A1 (en) 1994-11-23

Similar Documents

Publication Publication Date Title
AP9300508A0 (en) Compounds
GB9209628D0 (en) Compounds
GB9200245D0 (en) Compounds
GB9201755D0 (en) Compounds
GB9200210D0 (en) Compounds
GB9201694D0 (en) Compounds
GB9201693D0 (en) Compounds
GB9200209D0 (en) Compounds
GB9210632D0 (en) Compounds
GB9200566D0 (en) Compounds
GB9201751D0 (en) Compounds
GB9202792D0 (en) Compounds
GB9201692D0 (en) Compounds
GB9201746D0 (en) Compounds
GB9202827D0 (en) Compounds
GB9203172D0 (en) Compounds
GB9203173D0 (en) Compounds
GB9203174D0 (en) Compounds
GB9203175D0 (en) Compounds
GB9203176D0 (en) Compounds
GB9203177D0 (en) Compounds
GB9201744D0 (en) Compounds
GB9203182D0 (en) Compounds
GB9203468D0 (en) Compounds
GB9201748D0 (en) Compounds